Samrat Pharma reports net loss of Rs 1.63 crore in Q4

01 Jun 2012 Evaluate

Samrat Pharma has reported results for fourth quarter and year ended March 31, 2012.

The company has reported net loss of Rs 1.63 crore for the quarter ended March 31, 2012, against net  profit of Rs 0.35 crore for the corresponding period last fiscal. However, total income increased by 46.94% at Rs 15.59 crore during the quarter under review from Rs 10.61 crore in the year-ago period.

For the full year ended March 31, 2012, the company has posted a rise of 181.34% in its net profit at Rs 3.77 crore as compared to Rs 1.34 crore for the same period in the previous year. Total income has increased by 60.14% at Rs 69.55 crore for year under review as compared to Rs 43.43 crore for the period ended March 31, 2011.

Samrat Pharmachem Share Price

253.30 1.00 (0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×